Implanet SA Logo

Implanet SA

ISIN: FR0013470168 | Ticker: ALIMP | LEI: 969500CIMHFWNM4J4V14

About Implanet SA

Company Description

IMPLANET is an international company founded by European institutional and private investors, with headquarters near Bordeaux (FR) and a US subsidiary in Boston.

Implanet's focus is on products for the spine, knee and arthroscopy.

Implanet's flagship product, the latest generation Jazz™ implant, is designed to improve the treatment of spinal conditions requiring surgical spinal fusion. Jazz™ is protected by four groups of international patents and has 510(k) clearance from the U.S. Food and Drug Administration (FDA) as well as a CE mark.

Year founded

2006

Served area

Worldwide

Headcount

39

Headquarters

Technopole Bordeaux Montesquieu Allée François Magendie, 33650 Martillac – France

Filings & Publications

Shareholder information

Shares outstanding

19,691,801

IPO

July 11, 2017

Stock exchange(s)

Euronext Paris

Contact Investor Relations department

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.